Robert J. Spiegel Cyclacel Pharmaceuticals, Inc. (CYCC) insider trading activity

CYCC Quotes by TradingView

Robert J. Spiegel is Director of Cyclacel Pharmaceuticals, Inc.. Currently has a direct ownership of 39,415 shares of CYCC, which is worth approximately $24,831. The most recent transaction as insider was on Jun 30, 2023, when has been sold 21,219 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.4K
0% 3M change
0% 12M change
Total Value Held $24,831

Robert J. Spiegel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2023
BUY
Grant, award, or other acquisition
-
21,219 Added 35.0%
39,415 Common Stock
Jun 14 2022
BUY
Grant, award, or other acquisition
-
15,822 Added 46.51%
18,196 Common Stock
Jun 15 2021
BUY
Grant, award, or other acquisition
-
2,374 Added 50.0%
2,374 Common Stock

Also insider at

GERN
GERON CORP Healthcare
AYLA
Ayala Pharmaceuticals, Inc. Healthcare
Director
ATNX
Athenex, Inc. Healthcare
Director
ADXSD
Advaxis, Inc.
Director
RNXT
RenovoRx, Inc. Healthcare
Director
RJS

Robert J. Spiegel

Director
Buffalo, NY

Track Institutional and Insider Activities on CYCC

Follow Cyclacel Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYCC shares.

Notify only if

Insider Trading

Get notified when an Cyclacel Pharmaceuticals, Inc. insider buys or sells CYCC shares.

Notify only if

News

Receive news related to Cyclacel Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYCC